Who owns the EXTASHIELD trademark?

The EXTASHIELD trademark is owned by GlaxoSmithKline Biologicals SA.

What class is the EXTASHIELD trademark registered in?

The EXTASHIELD trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EXTASHIELD?

The USPTO serial number for EXTASHIELD is 98892137.

What is the registration number for EXTASHIELD?

EXTASHIELD is registered under USPTO registration number 8123340.

Sealvo

Home Search: EXTASHIELDEXTASHIELD #98892137

Back

Updated Oct 27, 2026·42 searches this week

View on USPTO TSDR Find similar marks

EXT

USPTO Trademark Record

REGISTERED

EXTASHIELD

SN 98892137·Reg 8123340·Filed Dec 09, 2024

Owner GlaxoSmithKline Biologicals SA

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EXTASHIELD (Serial No. 98892137), Registration No. 8123340, is a registered US trademark filed on Dec 09, 2024 by GlaxoSmithKline Biologicals SA. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 03, 2032

Mark Intelligence

EXTASHIELD (Reg. #8123340) is a registered US trademark that has been protecting its owner, GlaxoSmithKline Biologicals SA, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 09, 2024

SERIAL

98892137

REG#

8123340

REGISTERED

Feb 03, 2026

Filing Information

StatusREGISTERED

Filing DateDec 09, 2024

Serial Number98892137

Registration No.8123340

Registration DateFeb 03, 2026

Status DateFeb 03, 2026

Published for OppositionDec 16, 2025

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Feb 03, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 03, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Dec 16, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 16, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 10, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 16, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 17, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 17, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 17, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Oct 14, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 14, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 14, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Sep 16, 2025

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 16, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 16, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

SUSPENSION LETTER WRITTEN

May 30, 2025

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

May 30, 2025

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

May 30, 2025

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO EXAMINER

May 28, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Dec 09, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 09, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by GlaxoSmithKline Biologicals SA

Additional USPTO filings from the same owner.

VAX

VAXBEMVO

99718687

GlaxoSmithKline Biologicals SA

REGISTERED

ENG

ENGERIX-B

75022211

GLAXOSMITHKLINE BIOLOGICALS S.A

REGISTERED

SIM

SIMPLIFLU

87759152

GlaxoSmithKline Biologicals S.A.

REGISTERED

AXF

AXFLUNA

98891669

GlaxoSmithKline Biologicals SA

REGISTERED

Other Marks by Elizabeth K. Rucki

Additional USPTO filings handled by the same attorney of record.

LEY

LEYTOMIC

99588994

REGISTERED

VAM

VAMKESTO

99596753

REGISTERED

TUQ

TUQONTU

99596751

REGISTERED

ZOH

ZOHEYLA

99596765

REGISTERED

EXTASHIELD

Run a conflict check

Other Marks by GlaxoSmithKline Biologicals SA

Other Marks by Elizabeth K. Rucki

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company